Literature DB >> 3484775

Human monocyte production of interleukin-1: parameters of the induction of interleukin-1 secretion by lipopolysaccharides.

R C Newton.   

Abstract

The role of lipopolysaccharide (LPS) as an activator of human monocyte interleukin-1 (IL-1) synthesis and secretion has been examined in this study. The results demonstrate that when blood monocytes are prepared under low endotoxin conditions, they do not spontaneously secrete IL-1 activity. When cells are exposed to LPS extracted from different bacterial species, there is variation seen in the potency, with LPS from Salmonella species being the most potent in inducing IL-1 activity from human monocytes. This material is tenfold more potent than LPS obtained from three different strains of Escherichia coli and 10,000-fold more potent than material obtained from two other bacterial species. Detoxified endotoxins are inefficient activators for IL-1 secretion. When monocytes are exposed to LPS, there is a rapid rise in the level of IL-1 activity detected. Activity can be detected in cell lysates after 1 hr with appreciable accumulation seen over the first 6 hr of culture. This is accompanied by IL-1 release into the surrounding medium after 2 hr of culture with subsequent accumulation. Monocyte synthesis of IL-1 activity appears to be sensitive to fg/ml levels of Salmonella minnesota LPS, while appreciable secretion of this activity by monocytes requires pg/ml levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484775     DOI: 10.1002/jlb.39.3.299

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  The internalization time course of a given lipopolysaccharide chemotype does not correspond to its activation kinetics in monocytes.

Authors:  A Lentschat; V T El-Samalouti; J Schletter; S Kusumoto; L Brade; E T Rietschel; J Gerdes; M Ernst; H Flad; A J Ulmer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Monocyte zinc and in vitro prostaglandin E2 and interleukin-1 beta production by cultured peripheral blood monocytes in patients with Crohn's disease.

Authors:  H F Goode; B J Rathbone; J Kelleher; B E Walker
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

3.  Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Authors:  C D Rothermel; J Schachter; P Lavrich; E C Lipsitz; T Francus
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

4.  Spontaneous release of interleukin-1 (IL-1) from medullary mononuclear cells of pagetic subjects.

Authors:  G Pioli; G Girasole; M Pedrazzoni; P Sansoni; A Erroi; L Davoli; G Ciotti; A Mantovani; M Passeri
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

5.  Bikunin inhibits lipopolysaccharide-induced tumor necrosis factor alpha induction in macrophages.

Authors:  Hidenori Matsuzaki; Hiroshi Kobayashi; Tatsuo Yagyu; Kiyoshi Wakahara; Toshiharu Kondo; Noriyuki Kurita; Hideo Sekino; Kiyokazu Inagaki; Mika Suzuki; Naohiro Kanayama; Toshihiko Terao
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

6.  The role of leukocytes in the pathogenesis of fibrin deposition in bovine acute lung injury.

Authors:  B D Car; M M Suyemoto; N R Neilsen; D O Slauson
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Cytokine release from human peripheral blood leucocytes incubated with endotoxin with and without prior infection with influenza virus: relevance to the sudden infant death syndrome.

Authors:  J B Lundemose; H Smith; C Sweet
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

9.  Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells.

Authors:  J M Molina; D T Scadden; C Amirault; A Woon; E Vannier; C A Dinarello; J E Groopman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis.

Authors:  C Aime; S Cohen-Kaminsky; S Berrih-Aknin
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.